HDM2和p53蛋白的相互作用及其抑制剂的研究
被引量:5
Studies on the interaction of HDM2 and p53 and their inhibitors
摘要
HDM 2和 p5 3蛋白之间存在一个自动调节的负反馈环。通过抑制二者的相互作用可治疗肿瘤。近年来 ,寻找抑制这种相互作用的药物已成为肿瘤治疗的研究热点。
出处
《国外医学(肿瘤学分册)》
2002年第4期255-258,共4页
Foreign Medical Sciences (Cancer Section)
基金
国家自然科学基金资助项目 (3 9870 862 )
参考文献14
-
1Juven Gershon T, Oren M. Mdm2 : the ups and downs [J]. Mol Med, 1999, 5(2): 71-83.
-
2Momand J, Jung D, Wilczynski S, et al. The MDM2 gene amplification database[J]. Nucleic Acids Res, 1998, 26(15): 3453-3459.
-
3Garcia Echeverria C, Chene P, Blommers MJ, et al. Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53[J]. J Med Chem, 2000, 43(17): 3205-3208.
-
4Mayo LD, Turchi JJ, Berberich SJ. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53[J]. Cancer Res, 1997, 57(22): 5013-5016.
-
5Zhang Y, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways[J]. Cell, 1998, 92(6): 725-734.
-
6Lane DP, Hall PA. MDM2-arbiter of p53's destruction[J]. Trends Biochem Sci, 1997, 22(10): 372-374.
-
7Bottger A, Bottger V, Garcia Echeverria C, et al. Molecular characterization of the hdm2-p53 interaction[J]. J Mol Biol, 1997, 269(5): 744-756.
-
8Blaydes Jp, Gire V, Rowson JM, et al. Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regu-lation by mdm-2[J]. Oncogene, 1997, 14(15): 1859-1868.
-
9Wasylyk C, Salvi R, Argentini M, et al. p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53[J]. Oncogene, 1999, 18(11): 1921-1934.
-
10Chen L, Agrawal S, Zhou W, et al. Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage[J]. Proc Natl Acad Sci USA, 1998, 95(1): 195-200.
同被引文献27
-
1程玲,杨庆春,郑美蓉,车向新.MDM2在原发性肝细胞癌中的表达[J].中国组织化学与细胞化学杂志,2004,13(4):503-506. 被引量:5
-
2Flores C,Sobrevia L.Tumorogenesis and MDM2 protein.Rev Med Chil,2000,128: 539.
-
3Gougoulis V G,Zacharatos P,Mariatos G et al.Transcription factor E2F-1acts as a growth-promoting factor and is associated with adverse pronosis in non-small cell lung carcinomas.J Pathol,2002,198: 139.
-
4Leite K R,Franco M F,Srougi M et al.Abnormal expression of MDM2 in prostate carcinoma.Mod Pathol,2001,14: 428.
-
5Endo K,Ueda T,Ohta T et al.Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma.Liver,2000,20: 209.
-
6Attradi L D.The role of p53 in tumor suppression: lessons from mouse models.Cell Mol Life,1999,55: 48.
-
7Goussia A C,Ioachim E,Agnantis N J et al.Bcl-2 expression in colorectal tumours.Correlation with p53,MDM2,Rb proteins and proliferation indices.Histol Histopathol,2000,15: 667.
-
8Dawson R,Muller L,Dehner A et al.The N-terminal domain of p53 is natively unfolded.J Mol Biol,2003,332: 1131.
-
9Haines DS.The MDM2 proto-oncogene[J].Leuk Lymph,1997,26:227-238
-
10Martinez JC,Mateo M,Sanchez-Beato M,et al.MDM2 Expression in lymphoid cells and reactive and neoplastic lymphoid tissue.Comparative study with p53 expression [J].J Pathol 1995,177(1):27-34
引证文献5
-
1于莉娜,钟雪云,陈运贤,刘致中,秦艳芳,杜彬.人胶质瘤细胞株SWO-38异质性蛋白质分子机制的研究[J].中国神经肿瘤杂志,2003,1(4):205-208.
-
2高松源,钱碧云,陈华,刘岩雪.非霍奇金淋巴瘤中p53、MDM2表达与组织学类型及预后的关系[J].中国肿瘤临床,2004,31(13):764-766. 被引量:2
-
3郑美蓉,赵霞,杨木兰,阮幼冰.鼠双微粒体-2基因和突变型p53基因表达与肝癌细胞增殖和凋亡关系的研究[J].华中科技大学学报(医学版),2005,34(1):5-9.
-
4程玲,杨庆春,郑美蓉,车向新.MDM2在原发性肝细胞癌中的表达[J].中国组织化学与细胞化学杂志,2004,13(4):503-506. 被引量:5
-
5胡磊,毛汉文,沈雄山,黄政斌,李卫民,樊立.Mdm2基因在胰腺癌中的表达及其意义[J].中国普通外科杂志,2006,15(11):864-865. 被引量:2
二级引证文献7
-
1于雁,陈国华,胡靖,李悦,吴洪波,尚利华,孙萍.大肠癌中mdm2表达与临床相关性的研究[J].中国肿瘤临床,2006,33(5):264-266. 被引量:7
-
2胡磊,毛汉文,沈雄山,黄政斌,李卫民,樊立.Mdm2基因在胰腺癌中的表达及其意义[J].中国普通外科杂志,2006,15(11):864-865. 被引量:2
-
3熊首先,朱尤庆,何军.MDM2和p53在大肠癌组织中的表达及其意义[J].长江大学学报(自科版)(下旬),2007,4(1):11-13. 被引量:6
-
4陈现亮,高善玲,赵磊.MDM2在消化系肿瘤中作用的研究进展[J].世界华人消化杂志,2008,16(25):2877-2882. 被引量:5
-
5张鑫,康凯夫.小鼠双微体2基因在肿瘤中作用的研究进展[J].医学综述,2009,15(22):3363-3365. 被引量:3
-
6陈红,谢丽,刘宝瑞.MDM2作为肿瘤标志物的研究进展[J].临床肿瘤学杂志,2011,16(8):751-754. 被引量:4
-
7Hong Chen,Li Xie,Baorui Liu.Clinical significance of MDM2 as a tumor biomarker[J].The Chinese-German Journal of Clinical Oncology,2012,11(6):356-360.
-
1J.WilliamHarbour LoriWorley DuanduanMa MichaelCohen 李爱军.转导肽疗法用于葡萄膜黑色素瘤和视网膜母细胞瘤[J].美国医学会眼科杂志(中文版),2003,15(3):180-180.
-
2戴汉军(译).学术快讯[J].眼科,2006,15(6):421-421.
-
3徐亮(摘).能阻断Hdm2:p53复合物形成的抗肿瘤药物[J].国外医学(药学分册),2006,33(4):316-316.
-
4陈军,苗里宁,邹颖刚,贾妍,郑连文.PTEN缺失在肾透明细胞癌中的作用机制[J].中国老年学杂志,2012,32(8):1658-1660.
-
5王一阳.NUMB控制肿瘤抑制因子p53的活性[J].中国病理生理杂志,2008,24(2):356-356. 被引量:2
-
6卢星榕,易继林.SUMO-1对p53基因诱导HepG2细胞凋亡的增强作用[J].中国普外基础与临床杂志,2005,12(4):371-374.
-
7罗广文.NOMOS调强多叶准直器照射系统的维护[J].医疗装备,2005,18(11):46-47. 被引量:1
-
8孙永田.急食酿悲剧[J].新疆医药保健,2002(04S):20-21.
-
9旭辉.累出来的癌症该怎么防?[J].中华养生保健,2015,0(2):11-11.
-
10宋丽萍,邱曙东.P53-mdm2相互作用与肿瘤治疗策略[J].中国肿瘤生物治疗杂志,2005,12(4):303-305. 被引量:2